Dr. Zu-Chian Chiang, Fujian Normal University, China.
Zu-Chian Chiang, Ph.D. 🧬 is a distinguished Postdoctoral Fellow at the Biomedical Research Center of Southern China, Fujian Normal University. With a Ph.D. in Materials and Chemical Engineering from National United University, Taiwan, his research spans antibody-drug conjugates (ADCs), functional peptides, and biomaterials for cancer therapy 🧪. He has published in reputed journals, received multiple academic awards 🏆, and actively contributes as a peer reviewer. Dr. Chiang is dedicated to advancing translational biomedical research and cancer therapeutics 💉.
Professional Profile
Scopus Profile
🎓 Early Academic Pursuits
Dr. Zu-Chian Chiang’s academic journey began in Taiwan, where he earned his M.S. in Chemistry from Tunghai University (2005–2007) under the guidance of Prof. Feng-Di Lung. He later pursued a Ph.D. in Materials and Chemical Engineering at National United University (2008–2014), mentored by Prof. An-Chong Chao and Dr. Guo-Chung Dong. His early focus on chemical synthesis and biomedical engineering laid the foundation for his interdisciplinary research pursuits. 🧪📚
💼 Professional Endeavors
Dr. Chiang has served as a Postdoctoral Fellow across esteemed institutions in China and Taiwan, including the Biomedical Research Center of Southern China, Fujian Normal University, Academia Sinica, and National Taiwan University Hospital. His roles have encompassed technical platform support, translational medicine, and biotech innovation. His collaborative efforts with notable mentors such as Prof. Qi Chen and Dr. Andrew H.-J. Wang have enhanced his research acumen. 🔬🌏
🔬 Contributions and Research Focus On Biochemistry
Dr. Chiang’s research has consistently focused on functional peptides, biomacromolecular materials, and targeted therapies such as antibody-drug conjugates (ADCs) and aptamers. He has contributed significantly to cancer therapy and regenerative medicine, developing drug delivery systems that harness molecular precision. His projects include the development of CD47-targeting ADCs and HER2-specific therapeutic agents, showcasing innovation in tackling hard-to-treat cancers.
🌍 Impact and Influence
With an h-index of 5, 91 citations, and a Research Interest Score of 49.5, Dr. Chiang has made a measurable impact in biomedical sciences. His work on biomaterial scaffolds and cancer therapeutics is frequently cited in scientific literature and included in book chapters on hydroxyapatite and corticosteroid drug delivery. His publications in journals like Frontiers in Oncology, PLOS ONE, and Current Pharmaceutical Biotechnology reflect the translational value of his research.
🏆 Awards and Honors
Dr. Chiang has been recognized multiple times for his excellence in research and service:
-
2020 Science and Technology Commissioner, Quanzhou
-
2017 Chairman Award, Rotary International-Taiwan
-
2016 Biotech Elite Training Reserve Program Awardee
-
2012 Chung Hwa Rotary Doctoral Award
-
2010 Outstanding Doctoral Scholarship, National United University
These honors affirm his leadership and scholarly distinction in biomedical research.
🚀 Legacy and Future Contributions
Beyond research, Dr. Chiang is active in academic societies and Rotary International, serving in editorial and leadership roles. As a peer reviewer, club president, and society member, he contributes to the advancement of science and community service. Looking ahead, his work on precision cancer therapies, immunoengineering, and bioactive materials positions him as a key contributor to the future of personalized medicine and biomedical innovation. 🚀
📚Publications Top Notes
-
“Development of Novel CD47-Specific ADCs Possessing High Potency Against Non-Small Cell Lung Cancer in vitro and in vivo” (2022) 🧬
-
“Preparation and Characterization of Antibody-Drug Conjugates Acting on HER2-Positive Cancer Cells” (2020) 🧪
-
“Preparation and Characterization of Dexamethasone-Immobilized Chitosan Scaffold” (2012) 🏗️
-
“Characterization of the Morphology and Hydrophilicity of Chitosan/Caffeic Acid Hybrid Scaffolds” (2011) 🧫